Patents in the Postgenomic Era: Proprietary Drug Targets and Therapies

Published by: Drug and Market Development Publishing

Published: Oct. 1, 2005 - 180 Pages

Table of Contents

• Biomedical Innovation in the Postgenomic Era
  
• The Role of Patents in the Biomedical Industry
  
• Post-Genomic Technologies
  
• Established and Emerging Therapies
  
• Molecular Diagnostics
  

• What Is A Patent?
  
• Patents Require International Co-Operation
  
• Patents Are Time-Limited
  
• What Can Be Patented?
  
• Exceptions to Patentability
  
• US Utility Patents
  
• Grace Periods
  
• Post-Issue Challenges to Patent Validity
  
• Patenting Chemical Compounds
  
• Patenting Pharmaceuticals
  
• Patenting Natural Products
  
• Patenting Microbiological Inventions
  
• Patent Infringement
  

• Introduction
  
• Patenting of Genes
  
• Patenting of Proteins
  
• Regulatory Developments Relevant to Genes
  
• Regulatory Developments Relevant to Proteins
  
• Patent Claims and Risk of Litigation
  
• Solutions to the Patent Thicket Problem
  
• Issues Raised by Exclusive Licensing
  

• Patent Activity Survey: Aims and Methodology
  
• Overview of Therapy Areas
  
• Patent Activity in Major Drug Target Classes
  
• Patent Activity in Gene Therapy
  
• Patent Activity in Rna Interference
  
• Patent Activity in Pharmacogenomics
  
• Summary of Patent Activity Survey
  
• Analysis of Patents by Filing and Publication Year
  
• Analysis of Patent Maintenance
  
• Analysis of Patents By US Classification
  

• Mining Patents for Competitive Intelligence
  
• Patent Searching
  
• Indicators of Patent Quality
  
• Competitive Analysis of Biopatents Survey
  

• The Postgenomic Tide of Patents Has Risen
  
• Expanding the Universe of Drug Targets
  
• Using Patenting Trends to Guide Strategies
  
• Utilizing the Trade Secret System
  
• Recognizing Importance of Target Patents
  
• Anticipating Investors' Concerns
  
• Developing Litigation Awareness
  

Abstract

• Learn from past experiences with patenting of genes and proteins to secure potential drug targets by obtaining suitable patent protection
• Examine the results of a new survey of 9,972 postgenomic patents to assist the reader in predicting how soon products of genomics may reach advanced clinical trials
• Put patent mining theory into practice to identify potential threats and opportunities by effective use of resources and indicators of patent quality
• Build on competitive analysis of biopatents to assess your proprietary position by identifying your key competitors

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.